Chitinase-1 inhibition attenuates metabolic dysregulation and restores homeostasis in MASH animal models
Metabolomic reprogramming of the tumor microenvironment by dual arginase inhibitor OATD-02 boosts anticancer immunity
Comparative analysis of RNA 3D structure prediction methods: towards enhanced modeling of RNA-ligand interactions
Structure-Based Discovery of High-Affinity Small Molecule Ligands and Development of Tool Probes to Study the Role of Chitinase-3-Like Protein 1
Novel orally bioavailable piperidine derivatives as extracellular arginase inhibitors developed by a ring expansion
HPLC with Post-Column Derivatization with Alizarin for Determination of OATD-02, an Anticancer Arginase Inhibitor in Clinical Development
